This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
ACE inhibitors are commonly used for hypertension, but alternative therapies like bioactive peptides are needed.
Why it matters
Hypertension is a significant health risk, and understanding ACE's role can lead to better treatments. Exploring new therapies could improve patient outcomes.
How the study worked
This is a systematic review analyzing various ACE inhibitors, their side effects, and potential new treatments.
What this study cannot tell us
The study is a review and does not provide new experimental data; findings may not be directly applicable to all patient populations.
Read the original research
Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension.
Journal of the renin-angiotensin-aldosterone system : JRAAS, 2023, 7890188
Citation
Ahmad, Hafiz; Khan, Huma; Haque, Shabirul; Ahmad, Shameem; Srivastava, Namita; Khan, Azhar. (2023). Angiotensin-Converting Enzyme and Hypertension: A Systemic Analysis of Various ACE Inhibitors, Their Side Effects, and Bioactive Peptides as a Putative Therapy for Hypertension.. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2023, 7890188. https://doi.org/10.1155/2023/7890188